• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

The Disappointment of the NSABP C-08 Trial

  • — 16 Sep, 2009
The Disappointment of the NSABP C-08 Trial
Norman Wolmark
AudioMedica News
AudioMedica News
The Disappointment of the NSABP C-08 Trial
The Disappointment of the NSABP C-08 Trial
00:00 /
RSS Feed
Share
Link
Embed
Norman Wolmark

Norman Wolmark

Norman Wolmark on the study’s frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli.


LISTEN

[audio:https://www.audiomedica.com/podcasting/otbn/090914NormWomarkNiPetrelliPODCAST.mp3]

You may also like...

  • Conservative Breast Therapy Better for Men Superior Survival in Conservatively Treated Male Breast Cancer 13 Jul, 2018
  • Trifluridine with Tipiracil Lifts Survival in Refractory Gastric Cancer Trifluridine with Tipiracil Lifts Survival in Refractory Gastric Cancer 11 Oct, 2018
  • Adjuvant Checkpoint Inhibition Extends Disease-Free and Overall Survival in Patients with Stage III Melanoma Adjuvant Checkpoint Inhibition Extends Disease-Free and Overall Survival in Patients with Stage III Melanoma 13 Oct, 2016
  • Sibylle Loibl Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy 18 Dec, 2012
  • Previous story Healthcare Delivery And Spending: Big Impact On Cancer Survival
  • Next story No Shame No Blame: TB Stigma Removal “Toolkit” Launched in Zambia
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • New Front Line Standard for Older Patients with Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
  • Home
  • Oncology
  • The Disappointment of the NSABP C-08 Trial

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.